Enacts the pharmaceutical cost transparency act of 2017
Summary
Enacts the pharmaceutical cost transparency act requiring prescription drug manufacturers to file a report disclosing certain financial information pertaining to prescription drugs which have a wholesale acquisition cost of $10,000 or more annually or per course of treatment.
Bill status
in committee
1 of 4 stages cleared
Introduction
Mar 2017
Committee Review
Floor Vote
Governor
Introduced Mar 3, 2017
Last action Mar 3, 2017
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
1
Key actions
0
Committee
1
Mar 3, 2017
Senate · Referred to committee
REFERRED TO HEALTH
0 primary · 0 co-sponsors
Sponsors
No sponsor information available.
Ask Maddy
·
AI policy assistant
Ask Maddy about S 4986
Scope: NY
Hi! I can help you understand S 4986. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline